Personalized. Precision. Predictive. One size doesn’t fit all, especially when it comes to health care.
From personalized therapies using the patient’s own biological information to prescribe medications to machine learning techniques designed to improve health care analytics, Mason researchers are developing innovative new technologies, approaches, and interventions to promote health and enhance well-being.
Mason’s Institute for Biohealth Innovation (IBI)  unites faculty and student researchers across disciplines to enable the development of new technologies, approaches, and interventions to predict, prevent, treat, and eradicate disease, and improve care. Our world-class research community works hand-in-hand with individuals and organizations in the region and beyond to develop and implement innovations that have real-world impact.
“Mason has a deep commitment to conducting ‘research of consequence’, with partnership-enabled follow-through that ensures our innovations have impact in the world around us,” says Deb Crawford, Mason’s vice president for research. “nowhere is this more evident than in our IBI activities.”
Here is a closer look at some of the work being done in the areas of precision and predictive medicine at Mason.